Hyperfine, Inc. (HYPR) vs Myomo, Inc. (MYO)
Hyperfine, Inc. and Myomo, Inc. are both Medical Devices companies. Hyperfine, Inc. is the larger, with a market value of $84.4M against $64.6M — 1.3× the size. Hyperfine, Inc. grew revenue faster over the last twelve months: 53.2% against 6.14%. Myomo, Inc. has the higher net margin (−33.5% vs −210.8%) and the higher return on invested capital (−167.9% vs −401.8%). Across the 18 metrics below, Myomo, Inc. leads on 11 and Hyperfine, Inc. on 7.
Valuation
Profitability
| Metric | HYPR | MYO | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.41% | 68.35% | 56.01% |
| Operating margin | (203.27%) | (27.05%) | (15.03%) |
| Net margin | (210.75%) | (33.53%) | (20.40%) |
| Free cash flow margin | (166.48%) | (21.01%) | (7.24%) |
| Return on equity | (96.97%) | (123.76%) | (15.32%) |
| Return on assets | (64.40%) | (39.20%) | (19.72%) |
| Return on invested capital | (401.79%) | (167.90%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack